Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Finasteride doesn't affect hormone levels in normal men.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

Light microscopy is useful for diagnosing different hair disorders.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

BMI is not a significant predictor of complications after gender-affirming penile inversion vaginoplasty.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

The 2018 update to the ED care model added a new severity score and stressed a detailed evaluation of both physical and psychological aspects.

SSRI antidepressants can cause long-lasting sexual problems.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Post-finasteride patients show changes in gut bacteria, possibly causing various symptoms.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Hormonal changes during and after pregnancy can cause hair growth changes and hair loss, with treatments available for some conditions.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Primary care doctors should address female sexual dysfunctions to improve women's sexual health and life quality.

Transgender individuals face insurance barriers to gender-affirming surgery, needing policy reforms for better access.

Men with male-pattern baldness have higher levels of certain testosterone metabolites and may have more active androgen metabolism.

Some skin diseases and their treatments can negatively affect male fertility.

The document explains that hirsutism, often caused by hormonal issues, can be managed with treatment to improve both physical appearance and mental health.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Younger transgender women have surgery earlier, are mostly attracted to men, and show more preoperative depression that improves after surgery compared to older transgender women.